In hemangioendothelioma cells, ART time- and dose-dependently reduced tumor cell growth, concomitantly decreasing the expression of VEGF-A, VEGFR1, VEGFR2, and HIF-1α [46]. This evidence concerns the gene HIF1A and hemangioendothelioma.